Spirogen
VerifiedClinical stage biotechnology company specialising in novel, sequence-selective, DNA minor groove-binding molecule
Launch date
Employees
Ownership
Firm valuation
$105—150m (Dealroom.co estimates Oct 2009.)
London England (HQ)
Deals in current and previous year:
Financials
Edit| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E |
|---|---|---|---|---|---|---|---|
| Revenues | - | 1m | - | - | - | - | - |
Source: Company fillings or news article
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | £1m | Seed | |
| $15m | Growth Equity VC | ||
| N/A | Acquisition | ||
| Total Funding | $16.3m | ||
Recent News about Spirogen
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Spirogen
Edit
exited